FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Dendreon | Provenge | Regulators

SPOTLIGHT: Dendreon faces probe


Add the SEC to the list of problems faced by Dendreon. Regulators have begun an informal investigation of the company, which has seen its stock price rise and plunge as it has struggled to gain an approval for Provenge. Analysts say the SEC wants to see if any insider trading had been going on. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Dendreon   Provenge   Regulators